免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

Multi-target TMS for Schizophrenia Negative Symptoms

NCT:NCT07559084 · NOT_YET_RECRUITING

NCT编号NCT07559084
状态NOT_YET_RECRUITING
开始日期2026-10-01
完成时间2028-01-30
SponsorShanghai Mental Health Center (OTHER)
First posted
Last updated

简要摘要

This randomized controlled trial (RCT) is the first to evaluate the efficacy and safety of a multi-target TMS protocol targeting the right orbitofrontal cortex (R-OFC), left dorsolateral prefrontal cortex (L-DLPFC), and left inferior parietal lobule (L-IPL) for negative symptoms of schizophrenia.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑